Biopolym. Cell. 1998; 14(4):277-285.
http://dx.doi.org/10.7124/bc.0004D9
Генетичний аналіз варіантів ВІЛ-І в Україні
1Гребенюк В. А., 1Анопрієнко О. В., 1Скороход А. С., 2Марічев І. Л., 1Кавсан В. М.
  1. Інститут молекулярної біології і генетики НАН України
    Вул. Академіка Заболотного, 150, Київ, Україна, 03680
  2. Інститут епідеміології та інфекційних хвороб ім. Л. В. Громашевського АМН України
    вул. Амосова, 5, Київ, Україна, 03038

Abstract

Представлено перші результати аналізу нуклеотидних послідовностей генів вірусу імунодефіциту людини типу І (ВІЛ-І), отриманих за допомогою полімеразної ланцюгової реакції на ДНК з крові українських пацієнтів. Два з дев'яти досліджених зразків віднесено до підтипу А, інші — до підтипу В, Знайдено варіант ділянки V3 гена env ВІЛ-І; цей варіант зустрічається рідко. З двох показань щодо шляху передачі інфекції підтверджено одне.
Повний текст: (PDF, російською)

References

[1] HIV/AIDS: The Global Epidemic. Fact sheet. Geneva: UN AIDS and WHO 1996.
[2] Kobyshcha Yu, Mukharska L, Bochkova L et al. HIV in Ukraine. Informatsiynyy Bull. 9. Kyiv, 1996.
[3] Ivasyuk V, Kobyshcha Yu, Kordyum V et al. AIDS epidemic in Ukraine and abroad. Analitychnyy oglyad. Kyiv, 1996.
[4] Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984;224(4648):497-500.
[5] Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science. 1988;242(4882):1168-71.
[6] Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373(6510):123-6.
[7] Jin MJ, Hui H, Robertson DL, M?ller MC, Barr?-Sinoussi F, Hirsch VM, Allan JS, Shaw GM, Sharp PM, Hahn BH. Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J. 1994;13(12):2935-47.
[8] Muers G, Kcbert B, Hahn BH et. al. Human retroviruses and AIDS 1995. New Mexico: Los Alamos Nat. Lab. publ., 1995.
[9] Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, Ho DD. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I. J Virol. 1995;69(10):6122-30.
[10] Leitner T, Alaeus A, Marquina S, Lilja E, Lidman K, Albert J. Yet another subtype of HIV type 1? AIDS Res Hum Retroviruses. 1995;11(8):995-7.
[11] De Wolf F, Hogervorst E, Goudsmit J, Feny? EM, R?bsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SD, et al. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10(11):1387-400.
[12] Pau CP, Kai M, Holloman-Candal DL, Luo CC, Kalish ML, Schochetman G, Byers B, George JR. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10(11):1369-77.
[13] Cheingsong-Popov R, Lister S, Callow D, Kaleebu P, Beddows S, Weber J. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10(11):1379-86.
[14] Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Courouc? AM, Brun-V?zinet F, Simon F. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet. 1994;343(8910):1393-4.
[15] HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses. 1994;10(11):1327-43.
[16] Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, Burke DS. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses. 1994;10(5):561-7.
[17] Grez M, Dietrich U, Balfe P, von Briesen H, Maniar JK, Mahambre G, Delwart EL, Mullins JI, R?bsamen-Waigmann H. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J Virol. 1994;68(4):2161-8.
[18] Lukashov VV, Cornelissen MT, Goudsmit J, Papuashvilli MN, Rytik PG, Khaitov RM, Karamov EV, de Wolf F. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania. AIDS. 1995;9(5):435-9.
[19] Kalish ML, Luo CC, Weniger BG, Limpakarnjanarat K, Young N, Ou CY, Schochetman G. Early HIV type 1 strains in Thailand were not responsible for the current epidemic. AIDS Res Hum Retroviruses. 1994;10(11):1573-5.
[20] Brigido ER, Rossini M, Santos I. et al HIV-1 subtypes in female sexual partners of IDU at the San Paulo. XI Int. Conf. AIDS. Vancouver, 1996;Tu:C 220.
[21] Soto-Ramirez LE, Renjifo B, Marlink R, et al. Differential growth of HIV-1 subtypes in Langerhans cells. Relation to transmission route. XI Int. Conf. AIDS. Vancouver, 1996;Tu: A 370/
[22] Hillis DM, Huelsenbeck JP, Cunningham CW. Application and accuracy of molecular phylogenies. Science. 1994;264(5159):671-7.
[23] Ou CY, Ciesielski CA, Myers G, Bandea CI, Luo CC, Korber BT, Mullins JI, Schochetman G, Berkelman RL, Economou AN, et al. Molecular epidemiology of HIV transmission in a dental practice. Science. 1992;256(5060):1165-71.
[24] Holmes EC, Zhang LQ, Simmonds P, Rogers AS, Brown AJ. Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis. 1993;167(6):1411-4.
[25] Albert J, Wahlberg J, Leitner T, Escanilla D, Uhl?n M. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol. 1994;68(9):5918-24.
[26] Jaffe HW, McCurdy JM, Kalish ML, Liberti T, Metellus G, Bowman BH, Richards SB, Neasman AR, Witte JJ. Lack of HIV transmission in the practice of a dentist with AIDS. Ann Intern Med. 1994;121(11):855-9.
[27] Maniatis T, Fitsch EP, Sambrook J. Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Lab., 1982.
[28] Rogers MF, Ou CY, Rayfield M, Thomas PA, Schoenbaum EE, Abrams E, Krasinski K, Selwyn PA, Moore J, Kaul A, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med. 1989;320(25):1649-54.
[29] Nishimura A, Morita M, Nishimura Y, Sugino Y. A rapid and highly efficient method for preparation of competent Escherichia coli cells. Nucleic Acids Res. 1990;18(20):6169.
[30] Holmes DS, Quigley M. A rapid boiling method for the preparation of bacterial plasmids. Anal Biochem. 1981;114(1):193-7.
[31] Higgins DG, Bleasby AJ, Fuchs R. CLUSTAL V: improved software for multiple sequence alignment. Comput Appl Biosci. 1992;8(2):189-91.
[32] Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol. 1986;59(2):284-91.
[33] De Jong JJ, De Ronde A, Keulen W, Tersmette M, Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol. 1992;66(11):6777-80.
[34] Fern?ndez Medina RD, Jansson M, Halapi E, Russi JC, Libonatti O, Wigzell H. Genetic analysis of V3 domain sequences obtained from Uruguayan HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 1996;12(15):1491-3.
[35] Premkumar DR, Ma XZ, Maitra RK, Chakrabarti BK, Salkowitz J, Yen-Lieberman B, Hirsch MS, Kestler HW. The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res Hum Retroviruses. 1996;12(4):337-45.